RHUMBLINE ADVISERS – Eli Lilly and Company Transaction History
RHUMBLINE ADVISERS portfolio value:
$456.32M
portfolio value
RHUMBLINE ADVISERS quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.06% | 28.49K shares | 7.99M | $323.35 | 1.41M |
| Q2 2022 | share | Increase | +2.31% | 31.22K shares | 61.29M | $324.23 | 1.38M |
| Q1 2022 | share | Increase | +1.51% | 20.13K shares | 19.28M | $286.37 | 1.35M |
| Q4 2021 | share | Increase | +1.70% | 22.26K shares | 65.28M | $277.25 | 1.33M |
| Q3 2021 | share | Decrease | -2.78% | -37.47K shares | -6.59M | $230.3 | 1.30M |
| Q2 2021 | share | Decrease | -4.87% | -68.91K shares | 44.62M | $228.04 | 1.34M |
| Q1 2021 | share | Decrease | -6.35% | -95.98K shares | 9.24M | $184.81 | 1.41M |
| Q4 2020 | share | Decrease | -1.62% | -24.88K shares | 27.78M | $166.32 | 1.51M |
| Q3 2020 | share | Decrease | -0.95% | -14.78K shares | -27.25M | $145.05 | 1.53M |
| Q2 2020 | share | Increase | +6.83% | 99.10K shares | 53.24M | $160.1 | 1.55M |
| Q1 2020 | share | Decrease | -1.02% | -15.01K shares | 8.61M | $134.64 | 1.45M |
| Q4 2019 | share | Decrease | -1.19% | -17.65K shares | 26.78M | $126.91 | 1.46M |
| Q3 2019 | share | Increase | +1.98% | 28.86K shares | 4.74M | $107.36 | 1.48M |
| Q2 2019 | share | Decrease | -4.50% | -68.66K shares | -36.52M | $105.74 | 1.45M |
| Q1 2019 | share | Decrease | -0.92% | -14.14K shares | 19.76M | $123.17 | 1.52M |
| Q4 2018 | share | Increase | +0.85% | 12.96K shares | 14.33M | $109.26 | 1.53M |
| Q3 2018 | share | Decrease | -2.07% | -32.18K shares | 30.78M | $100.8 | 1.52M |
| Q2 2018 | share | Increase | +1.21% | 18.58K shares | 13.83M | $79.72 | 1.55M |
| Q1 2018 | share | Decrease | -2.38% | -37.50K shares | -14.08M | $71.78 | 1.53M |
| Q4 2017 | share | Increase | +2.29% | 35.34K shares | 1.32M | $77.79 | 1.57M |
| Q3 2017 | share | Decrease | -3.65% | -58.42K shares | 186K | $78.29 | 1.54M |
| Q2 2017 | share | Increase | +1.32% | 20.87K shares | -1.14M | $74.85 | 1.59M |
| Q1 2017 | share | Increase | +5.29% | 79.28K shares | 22.50M | $76 | 1.57M |
| Q4 2016 | share | Increase | +3.13% | 45.51K shares | -6.41M | $66.02 | 1.49M |
| Q3 2016 | share | Increase | +3.89% | 54.40K shares | 6.48M | $71.57 | 1.45M |
| Q2 2016 | share | Increase | +4.39% | 58.82K shares | 13.67M | $69.79 | 1.39M |
| Q1 2016 | share | Increase | +3.02% | 39.34K shares | -13.11M | $63.39 | 1.34M |